Multifaceted Effects of Delta Opioid Receptors and DADLE in Diseases of the Nervous System

E-ISSN： 1875-6220|15|2|94-108

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.15, Iss.2, 2018-04, pp. : 94-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabotropic Glutamate Receptors in Central Nervous System Diseases

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 538-616

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of ornithine decarboxylase activity in developing rat tissues by central nervous system -endorphin is mediated by -opioid receptors, but not by - or -opioid receptors

By Bartolome J.V. Kwen-Jen C. Bartolome M.B.

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 43-50

Elsevier

Access to resources Recommend Favorite

Recent progress in 5-HT₇ receptors: potential treatment of central and peripheral nervous system diseases

By Slassi Abdelmalik Isaac Methvin Xin Tao

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 1009-1027

Informa Healthcare

Access to resources Recommend Favorite

The Therapeutic Potential of Sigma (σ ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 884-901

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Mu and Delta Opioid Receptors in Alcohol Drinking Behaviour

Current Drug Abuse Reviews, Vol. 1, Iss. 2, 2008-06 ,pp. : 239-252

Bentham Science Publishers

Access to resources Recommend Favorite